Literature DB >> 21439331

Depressive-like behaviour of mice lacking cellular prion protein.

Vinicius M Gadotti1, Stephan P Bonfield, Gerald W Zamponi.   

Abstract

Cellular Prion Protein (PrP(C)) is known to mediate a protective role in several neurological conditions such as ischemia and epilepsy. However, so far, little information is available concerning the role of PrP(C) in psychiatric disorders such as depression. Here, we have used PrP(C) null mice to examine a putative role of PrP(C) in depressive-like states. Prion protein null mice exhibited depressive-like behaviour when compared to wild-type mice in both the Forced Swimming Test (FST) and Tail Suspension Test (TST). The clinical antidepressant drug imipramine and the NMDA receptor antagonist MK-801 reversed the depressive-like behaviour observed for knockout mice in the TST. The present data thus indicate that PrP(C) exerts a critical role in modulating the depressive-like state in mice, reinforcing the notion that PrP(C) might be associated with alterations in mood disorder states, and suggests a possible role of PrP(C) as a potential drug target for treating depressive disorders.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439331     DOI: 10.1016/j.bbr.2011.03.012

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  20 in total

Review 1.  Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.

Authors:  Peter K Stys; Haitao You; Gerald W Zamponi
Journal:  J Physiol       Date:  2012-02-06       Impact factor: 5.182

2.  A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease.

Authors:  Danielle Beckman; Rafael Linden
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

3.  Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expression.

Authors:  Matthias Schmitz; Catharina Greis; Philipp Ottis; Christopher J Silva; Walter J Schulz-Schaeffer; Arne Wrede; Katharina Koppe; Bruce Onisko; Jesús R Requena; Nambirajan Govindarajan; Carsten Korth; Andre Fischer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2014-03-07       Impact factor: 5.590

4.  Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity.

Authors:  Franc Llorens; José Antonio Del Río
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

5.  Behavioral abnormalities in prion protein knockout mice and the potential relevance of PrP(C) for the cytoskeleton.

Authors:  Matthias Schmitz; Saima Zafar; Christopher J Silva; Inga Zerr
Journal:  Prion       Date:  2014       Impact factor: 3.931

6.  Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice.

Authors:  Danielle Beckman; Luis E Santos; Tatiana A Americo; Jose H Ledo; Fernando G de Mello; Rafael Linden
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

Review 7.  Prion protein scrapie and the normal cellular prion protein.

Authors:  Caroline J Atkinson; Kai Zhang; Alan L Munn; Adrian Wiegmans; Ming Q Wei
Journal:  Prion       Date:  2016       Impact factor: 3.931

Review 8.  Gene expression resulting from PrPC ablation and PrPC overexpression in murine and cellular models.

Authors:  Franc Llorens; Isidre Ferrer; José Antonio del Río
Journal:  Mol Neurobiol       Date:  2013-08-16       Impact factor: 5.590

9.  Cellular prion protein protects from inflammatory and neuropathic pain.

Authors:  Vinicius M Gadotti; Gerald W Zamponi
Journal:  Mol Pain       Date:  2011-08-16       Impact factor: 3.395

10.  SIRPα polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells.

Authors:  Mario Nuvolone; Veronika Kana; Gregor Hutter; Daiji Sakata; Steven M Mortin-Toth; Giancarlo Russo; Jayne S Danska; Adriano Aguzzi
Journal:  J Exp Med       Date:  2013-10-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.